New medicine Toviaz launched for overactive bladder

Pfizer Korea said it has released a new prescription drug called Toviaz (fesoterodine fumarate) to treat overactive bladder (OAB) in adults.

Toviaz, which is taken once daily, is available as an extended-release tablet in doses of 4 or 8 milligrams. The recommended starting dose is 4 milligrams, which can be increased to 8 milligrams if needed, based upon individual response and tolerability...